Healthcare Analytics Market by Type (Predictive, Diagnostic), Application (Claim, RCM, Fraud, Precision Health, RWE, Imaging, Supply Chain, Workforce, Population Health), EndUser (Payer, Hospital, ACO, ASC, Govt, Clinic), & Region: Global Forecast to 2029
The global Healthcare analytics market is projected to reach 133.19 billion by 2029 from 44.83 billion in 2024, at a CAGR of 24.3 % from 2024 to 2029. The widespread adoption of Electronic Health Records (EHR) is accelerating the growth of the healthcare analytics market. In North America, approximately 78% of office-based physicians and 96% of non-federal acute care hospitals use EHR systems, which are supported by regulatory incentives such as the HITECH Act. Europe has varying adoption rates, with the Netherlands at 97% and an average of 81% across the continent, indicating a high potential for analytics integration. Increased adoption of EHRs improves data accessibility and drives the demand for advanced analytics solutions.
“Healthcare analytics , clinical analytics segment to witness the highest growth during the forecast period.”
Based on application, the healthcare analytics market is segmented into financial analytics, clinical analytics, operations & administrative analytics and population health analytics. The clinical analytics segment held the largest market share in 2023. Value-Based Care, technological advancements, and improved patient outcomes drive clinical analytics growth by focusing on outcome-based performance, optimizing costs, and enabling personalized, data-driven care through AI and EHR systems. This enhances care quality and efficiency, boosting the healthcare analytics market.
“APAC is estimated to register the highest CAGR during the forecast period.”
In this report, the healthcare analytics market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The healthcare analytics market in APAC is projected to register the highest CAGR rate during the forecast period. The APAC healthcare analytics market is groqing due to affordable medical treatments, such as average cost of bypass surgery in APAC region is approximately USD 4000, compared to USD 30,000 to USD 200,000 in the US. Moreover, government support for medical tourism, healthcare infrastructure investment, IT expansion, and a growing aging population with chronic diseases collectively strengthen the region's position in global healthcare.
In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the authentication and brand protection marketplace.
The study includes an in-depth competitive analysis of these key players in the healthcare analytics market, with their company profiles, recent developments, and key market strategies.
Research Coverage
This research report categorizes the healthcare analytics market by component (Services, Software), by type (Descriptive analytics, Predictive analytics, Prescriptive analytics, Diagnostic analytics), by application (Financial analytics, Clinical analytics, Operations & Administration analytics, Population Health analytics), by end-user (Payers, Providers, Pharmaceutical & Medical device supply chain) and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the healthcare analytics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the healthcare analytics market. Competitive analysis of upcoming startups in the healthcare analytics market ecosystem is covered in this report.
Reasons to buy this report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the healthcare analytics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
“Healthcare analytics , clinical analytics segment to witness the highest growth during the forecast period.”
Based on application, the healthcare analytics market is segmented into financial analytics, clinical analytics, operations & administrative analytics and population health analytics. The clinical analytics segment held the largest market share in 2023. Value-Based Care, technological advancements, and improved patient outcomes drive clinical analytics growth by focusing on outcome-based performance, optimizing costs, and enabling personalized, data-driven care through AI and EHR systems. This enhances care quality and efficiency, boosting the healthcare analytics market.
“APAC is estimated to register the highest CAGR during the forecast period.”
In this report, the healthcare analytics market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The healthcare analytics market in APAC is projected to register the highest CAGR rate during the forecast period. The APAC healthcare analytics market is groqing due to affordable medical treatments, such as average cost of bypass surgery in APAC region is approximately USD 4000, compared to USD 30,000 to USD 200,000 in the US. Moreover, government support for medical tourism, healthcare infrastructure investment, IT expansion, and a growing aging population with chronic diseases collectively strengthen the region's position in global healthcare.
In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the authentication and brand protection marketplace.
- By Company Type: Tier 1 – 45%, Tier 2 – 35%, and Tier 20%
- By Designation: C-level Executives – 50%, Directors – 30%, and Others – 20%
- By Region: North America– 40%, Europe – 35%, Asia Pacific– 20% and RoW- 5%
The study includes an in-depth competitive analysis of these key players in the healthcare analytics market, with their company profiles, recent developments, and key market strategies.
Research Coverage
This research report categorizes the healthcare analytics market by component (Services, Software), by type (Descriptive analytics, Predictive analytics, Prescriptive analytics, Diagnostic analytics), by application (Financial analytics, Clinical analytics, Operations & Administration analytics, Population Health analytics), by end-user (Payers, Providers, Pharmaceutical & Medical device supply chain) and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the healthcare analytics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the healthcare analytics market. Competitive analysis of upcoming startups in the healthcare analytics market ecosystem is covered in this report.
Reasons to buy this report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the healthcare analytics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (Government initiatives to increase EHR adoption, Growing venture capital investments in healthcare analytics start-ups, Growing pressure to curb healthcare spending and improve patient outcomes, Heterogeneity and complexity of big data in healthcare, Growing focus on real-world evidence, Cost Management and Operational Efficiency, Rise of Telemedicine and Remote Monitoring, Regulatory Compliance and Quality Improvement, Increasing demand for data-driven decision-making), restraints (High cost of analytics solutions in healthcare organizations, Rising data breach concerns), opportunities (Increasing focus on value-based medicines, Use of analytics in precision and personalized medicines, Cloud-based analytics, Increasing number of patient registries, Emergence of social media and its impact on healthcare industry, Augmented analytics to supplement human intelligence, Analytics of healthcare things), and challenges (Concerns regarding inaccurate and inconsistent data, Reluctance to adopt healthcare analytics solutions in emerging countries, Data integration for coordinated care, Operational gaps between payers and providers, Dearth of skilled personnel) influencing the growth of the healthcare analytics market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare analytics market
- Market Development: Comprehensive information about lucrative markets – the report analyses the healthcare analytics market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the healthcare analytics market
- Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Merative (US), Optum, Inc.(US), SAS Institute Inc. (US), Oracle (US), Citiustech Inc (US), Inovalon (US), Mckesson Corporation (US), MedeAnalytics, Inc.(US), Cotiviti, Inc. (US), Exlservice Holdings, Inc. (US), Wipro (India), Apixio. (US); among others in healthcare analytics market
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 IMPACT OF AI/GEN AI
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
2.2 RESEARCH METHODOLOGY DESIGN
2.3 MARKET SIZE ESTIMATION METHODOLOGY
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 HEALTHCARE ANALYTICS MARKET OVERVIEW
4.2 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SHARE, BY END USER AND COUNTRY (2023)
4.3 HEALTHCARE ANALYTICS MARKET, BY COUNTRY
4.4 HEALTHCARE ANALYTICS MARKET: REGIONAL MIX
4.5 HEALTHCARE ANALYTICS MARKET: EMERGING ECONOMIES VS. DEVELOPED COUNTRIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Favorable government initiatives for electronic health record adoption
5.2.1.2 Growing venture capital investments in startups
5.2.1.3 Need to reduce healthcare costs
5.2.1.4 Increasing focus on real-world evidence
5.2.1.5 Rise of telemedicine and remote patient monitoring
5.2.1.6 Growing focus on regulatory compliance
5.2.2 RESTRAINTS
5.2.2.1 High cost of analytics solutions
5.2.2.2 Growing concerns about data breach
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing focus on value-based medicines
5.2.3.2 Growing use of analytics in healthcare
5.2.3.3 Rising number of patient registries
5.2.3.4 Emergence of social media and digital health technologies
5.2.4 CHALLENGES
5.2.4.1 Concerns regarding inaccurate and inconsistent data
5.2.4.2 Reluctance to adopt healthcare analytics solutions in developing countries
5.2.4.3 Lack of maintenance of medical records
5.2.4.4 Shortage of skilled personnel
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 INDUSTRY TRENDS
5.4.1 INCREASING PARTNERSHIPS AND COLLABORATIONS AMONG MARKET PLAYERS
5.4.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS
5.4.3 GROWING ADOPTION OF CLOUD-BASED IT SOLUTIONS
5.5 ECOSYSTEM ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 TECHNOLOGY ANALYSIS
5.7.1 KEY TECHNOLOGIES
5.7.1.1 Big data analytics
5.7.1.2 Artificial intelligence and machine learning
5.7.1.3 Business intelligence tools
5.7.2 ADJACENT TECHNOLOGIES
5.7.2.1 Cloud computing
5.7.2.2 Internet of things
5.8 REGULATORY LANDSCAPE
5.8.1 REGULATORY ANALYSIS
5.8.2 GOVERNMENT REGULATIONS
5.8.2.1 US
5.8.2.2 Europe
5.8.2.3 China
5.8.2.4 Japan
5.8.2.5 India
5.8.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT
5.9.2 AVERAGE SELLING PRICE, BY REGION
5.10 PORTER’S FIVE FORCES ANALYSIS
5.11 PATENT ANALYSIS
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.12.2 BUYING CRITERIA
5.13 END-USER ANALYSIS
5.13.1 UNMET NEEDS
5.13.2 END-USER EXPECTATIONS
5.14 KEY CONFERENCES AND EVENTS, 2024–2025
5.15 CASE STUDY ANALYSIS
5.16 BUSINESS MODEL ANALYSIS
5.17 INVESTMENT AND FUNDING SCENARIO
5.18 IMPACT OF AI/GEN AI ON HEALTHCARE ANALYTICS MARKET
5.18.1 KEY USE CASES
5.18.2 CASE STUDY ON AI/GEN AI
5.18.3 ADJACENT MARKET ECOSYSTEM
5.18.3.1 Life science analytics market
5.18.3.2 Healthcare IT market
5.18.3.3 Healthcare fraud analytics market
5.18.4 USER READINESS AND IMPACT ASSESSMENT
5.18.4.1 User readiness
5.18.4.1.1 Payers
5.18.4.1.2 Providers
5.18.4.2 Impact assessment
5.18.4.2.1 User A: Payers
5.18.4.2.1.1 Implementation
5.18.4.2.1.2 Impact
5.18.4.2.2 User B: Providers
5.18.4.2.2.1 Implementation
5.18.4.2.2.2 Impact
6 HEALTHCARE ANALYTICS MARKET, BY COMPONENT
6.1 INTRODUCTION
6.2 SERVICES
6.2.1 MANAGED SERVICES
6.2.1.1 Analytical services
6.2.1.1.1 Increasing volume of healthcare data to facilitate growth
6.2.1.2 Consulting services
6.2.1.2.1 Need to improve clinical outcomes and patient satisfaction to support growth
6.2.2 PROFESSIONAL SERVICES
6.2.2.1 Training & implementation services
6.2.2.1.1 Growing emphasis on value-based care and specialized training services to drive market
6.2.2.2 Maintenance & support services
6.2.2.2.1 Expanding research needs to propel demand for maintenance & support services
6.3 SOFTWARE
6.3.1 ON-PREMISE SOFTWARE
6.3.1.1 Provision of multi-vendor architecture and security benefits to drive market
6.3.2 CLOUD-BASED SOFTWARE
6.3.2.1 Real-time analysis and elimination of purchasing costs for software & hardware to drive adoption
7 HEALTHCARE ANALYTICS MARKET, BY TYPE
7.1 INTRODUCTION
7.2 DESCRIPTIVE ANALYTICS
7.2.1 INCREASING USE IN PATIENT POPULATION MANAGEMENT AND FINANCIAL MANAGEMENT TO BOOST MARKET
7.3 PREDICTIVE ANALYTICS
7.3.1 ABILITY OF PREDICTIVE ANALYTICS TO HELP HEALTHCARE ORGANIZATIONS AVOID PREVENTABLE EVENTS TO SUPPORT GROWTH
7.4 PRESCRIPTIVE ANALYTICS
7.4.1 NEED FOR BETTER TREATMENT METHODS AND BUSINESS PRACTICES TO ENCOURAGE GROWTH
7.5 DIAGNOSTIC ANALYTICS
7.5.1 RISE IN LAUNCHES OF AI-DRIVEN ANALYTICS PRODUCTS AND SERVICES TO EXPEDITE GROWTH
8 HEALTHCARE ANALYTICS MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 FINANCIAL ANALYTICS
8.2.1 CLAIMS PROCESSING
8.2.1.1 Increasing shift from paper-based claims processing to electronic mode to augment growth
8.2.2 REVENUE CYCLE MANAGEMENT
8.2.2.1 Growing focus on financial forecasting and budgeting process to boost market
8.2.3 PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE
8.2.3.1 Implementation of ICD-10 code sets and adoption of fee-for-value systems to drive market
8.2.4 RISK ADJUSTMENT & ASSESSMENT
8.2.4.1 Rise in special enrollment periods and new subsidies to accelerate growth
8.3 CLINICAL ANALYTICS
8.3.1 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
8.3.1.1 Growing adoption of benchmarking to identify negative issues impacting healthcare systems to drive market
8.3.2 CLINICAL DECISION SUPPORT
8.3.2.1 Need to reduce medical errors and expedite diagnosis to boost market
8.3.3 REPORTING & COMPLIANCE
8.3.3.1 Ability to track regulatory changes, assess non-compliance, and perform internal audits to sustain growth
8.3.4 COMPARATIVE ANALYTICS/EFFECTIVENESS
8.3.4.1 Growing adoption of electronic health records to fuel market
8.3.5 PRECISION HEALTH/REAL-WORLD EVIDENCE
8.3.5.1 Strong government support for personalized medicine to sustain growth
8.3.6 MEDICAL IMAGING ANALYTICS
8.3.6.1 Ability to provide real-time insights and diagnosis of genetic disorders to aid growth
8.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS
8.4.1 SUPPLY CHAIN ANALYTICS
8.4.1.1 Growing need to reduce healthcare costs and implement better inventory management practices to fuel market
8.4.2 WORKFORCE ANALYTICS
8.4.2.1 Need for effective recruitment to favor growth
8.4.3 STRATEGIC ANALYTICS
8.4.3.1 Growing use of advanced analytics tools for geographic expansion and service line expansion to drive market
8.5 POPULATION HEALTH ANALYTICS
8.5.1 RISING USE IN CLINICAL OUTCOME ENGAGEMENT AND POPULATION RISK MANAGEMENT TO SPUR GROWTH
9 HEALTHCARE ANALYTICS MARKET, BY END USER
9.1 INTRODUCTION
9.2 PAYERS
9.2.1 PRIVATE INSURANCE COMPANIES
9.2.1.1 Increasing reliance on analytics for fraud prevention and claims processing to contribute to growth
9.2.2 GOVERNMENT AGENCIES
9.2.2.1 Rising use of analytics solutions to maximize payment accuracy and set reimbursement rates to boost market
9.3 PROVIDERS
9.3.1 HOSPITALS & CLINICS
9.3.1.1 Growing adoption of healthcare analytics solutions by large hospitals, medical groups, and physician practices to boost market
9.3.2 POST-ACUTE CARE ORGANIZATIONS
9.3.2.1 Increasing use of analytics solutions to review and study patient data to drive market
9.3.3 AMBULATORY SURGERY CENTERS
9.3.3.1 Need to control healthcare costs to support market
9.3.4 OTHER PROVIDERS
9.4 PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN
9.4.1 MANUFACTURERS
9.4.1.1 Growing adoption of digital technologies to drive market
9.4.2 DISTRIBUTORS & WHOLESALERS
9.4.2.1 Need for improved supply chain operations, inventory management, and service delivery to boost market
9.4.3 RETAILERS
9.4.3.1 Rising integration of healthcare analytics into retail operations to stimulate growth
10 HEALTHCARE ANALYTICS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 High adoption of electronic health records to drive market
10.2.3 CANADA
10.2.3.1 Need for managing patient volumes, clinical data, and healthcare costs to favor market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Government initiatives to increase use of analytics in healthcare
10.3.3 UK
10.3.3.1 Availability of venture capital investments to drive market
10.3.4 FRANCE
10.3.4.1 Strong financial support for digital health to augment market
10.3.5 ITALY
10.3.5.1 Growing number of drug approvals to drive uptake of analytics solutions
10.3.6 SPAIN
10.3.6.1 Growing adoption of personalized medicine to drive market
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Rising geriatric population to drive demand for effective patient management solutions
10.4.3 CHINA
10.4.3.1 Favorable reforms and growing number of electronic health records to aid growth
10.4.4 INDIA
10.4.4.1 Favorable government initiatives to fuel market
10.4.5 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Growing adoption of digital solutions in healthcare to boost market
10.5.3 MEXICO
10.5.3.1 Growing prominence of startups and rising R&D activity to propel market
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Rising investments, advancements, and developing healthcare infrastructure to drive market
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2024
11.3 REVENUE ANALYSIS, 2019–2023
11.4 MARKET SHARE ANALYSIS, 2023
11.5 COMPANY EVALUATION AND FINANCIAL METRICS
11.6 BRAND/SOFTWARE COMPARISON
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.7.1 STARS
11.7.2 EMERGING LEADERS
11.7.3 PERVASIVE PLAYERS
11.7.4 PARTICIPANTS
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.7.5.1 Company footprint
11.7.5.2 Region footprint
11.7.5.3 Component footprint
11.7.5.4 Application footprint
11.7.5.5 End-user footprint
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.8.1 PROGRESSIVE COMPANIES
11.8.2 RESPONSIVE COMPANIES
11.8.3 DYNAMIC COMPANIES
11.8.4 STARTING BLOCKS
11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.8.5.1 Detailed list of key startups/SMEs
11.8.5.2 Competitive benchmarking of key startups/SMEs
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES
11.9.2 DEALS
11.9.3 EXPANSIONS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 MERATIVE
12.1.1.1 Business overview
12.1.1.2 Products/Solutions/Services offered
12.1.1.3 Recent developments
12.1.1.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.1.3.2 Deals
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 SAS INSTITUTE INC.
12.1.2.1 Business overview
12.1.2.2 Products/Solutions/Services offered
12.1.2.3 Recent developments
12.1.2.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 OPTUM, INC.
12.1.3.1 Business overview
12.1.3.2 Products/Solutions/Services offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 ORACLE
12.1.4.1 Business overview
12.1.4.2 Products/Solutions/Services offered
12.1.4.3 Recent developments
12.1.4.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.4.3.2 Deals
12.1.4.3.3 Expansions
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses and competitive threats
12.1.5 VERADIGM LLC
12.1.5.1 Business overview
12.1.5.2 Products/Solutions/Services offered
12.1.5.3 Recent developments
12.1.5.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.5.3.2 Deals
12.1.5.3.3 Expansions
12.1.5.3.4 Other developments
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses and competitive threats
12.1.6 EXLSERVICE HOLDINGS, INC.
12.1.6.1 Business overview
12.1.6.2 Products/Solutions/Services offered
12.1.6.3 Recent developments
12.1.6.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.6.3.2 Deals
12.1.6.3.3 Other developments
12.1.7 CITIUSTECH INC.
12.1.7.1 Business overview
12.1.7.2 Products/Solutions/Services offered
12.1.7.3 Recent developments
12.1.7.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.7.3.2 Deals
12.1.7.3.3 Expansions
12.1.7.3.4 Other developments
12.1.8 HEALTH CATALYST
12.1.8.1 Business overview
12.1.8.2 Products/Solutions/Services offered
12.1.8.3 Recent developments
12.1.8.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.8.3.2 Deals
12.1.9 CVS HEALTH
12.1.9.1 Business overview
12.1.9.2 Products/Solutions/Services offered
12.1.9.3 Recent developments
12.1.9.3.1 Deals
12.1.10 INOVALON
12.1.10.1 Business overview
12.1.10.2 Products/Solutions/Services offered
12.1.10.3 Recent developments
12.1.10.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.10.3.2 Deals
12.1.10.3.3 Expansions
12.1.10.3.4 Other developments
12.1.11 MCKESSON CORPORATION
12.1.11.1 Business overview
12.1.11.2 Products/Solutions/Services offered
12.1.11.3 Recent developments
12.1.11.3.1 Deals
12.1.12 MEDEANALYTICS, INC.
12.1.12.1 Business overview
12.1.12.2 Products/Solutions/Services offered
12.1.12.3 Recent developments
12.1.12.3.1 Deals
12.1.12.3.2 Other developments
12.1.13 COTIVITI, INC.
12.1.13.1 Business overview
12.1.13.2 Products/Solutions/Services offered
12.1.13.3 Recent developments
12.1.13.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.13.3.2 Other developments
12.1.14 APIXIO, INC.
12.1.14.1 Business overview
12.1.14.2 Products/Solutions/Services offered
12.1.14.3 Recent developments
12.1.14.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.14.3.2 Deals
12.1.15 ENLITIC
12.1.15.1 Business overview
12.1.15.2 Products/Solutions/Services offered
12.1.15.3 Recent developments
12.1.15.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.15.3.2 Deals
12.1.16 KOMODO HEALTH, INC.
12.1.16.1 Business overview
12.1.16.2 Products/Solutions/Services offered
12.1.16.3 Recent developments
12.1.16.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.16.3.2 Deals
12.1.17 HEALTHEC, LLC
12.1.17.1 Business overview
12.1.17.2 Products/Solutions/Services offered
12.1.17.3 Recent developments
12.1.17.3.1 Deals
12.1.18 IQVIA
12.1.18.1 Business overview
12.1.18.2 Products/Solutions/Services offered
12.1.18.3 Recent developments
12.1.18.3.1 Deals
12.1.19 WIPRO
12.1.19.1 Business overview
12.1.19.2 Products/Solutions/Services offered
12.2 OTHER PLAYERS
12.2.1 ARCADIA SOLUTIONS, LLC.
12.2.2 EVIDATION HEALTH, INC.
12.2.3 HEALTHCORUM
12.2.4 AETION, INC.
12.2.5 TREDENCE.INC.
12.2.6 SISENSE LTD.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 IMPACT OF AI/GEN AI
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
2.2 RESEARCH METHODOLOGY DESIGN
2.3 MARKET SIZE ESTIMATION METHODOLOGY
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 HEALTHCARE ANALYTICS MARKET OVERVIEW
4.2 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SHARE, BY END USER AND COUNTRY (2023)
4.3 HEALTHCARE ANALYTICS MARKET, BY COUNTRY
4.4 HEALTHCARE ANALYTICS MARKET: REGIONAL MIX
4.5 HEALTHCARE ANALYTICS MARKET: EMERGING ECONOMIES VS. DEVELOPED COUNTRIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Favorable government initiatives for electronic health record adoption
5.2.1.2 Growing venture capital investments in startups
5.2.1.3 Need to reduce healthcare costs
5.2.1.4 Increasing focus on real-world evidence
5.2.1.5 Rise of telemedicine and remote patient monitoring
5.2.1.6 Growing focus on regulatory compliance
5.2.2 RESTRAINTS
5.2.2.1 High cost of analytics solutions
5.2.2.2 Growing concerns about data breach
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing focus on value-based medicines
5.2.3.2 Growing use of analytics in healthcare
5.2.3.3 Rising number of patient registries
5.2.3.4 Emergence of social media and digital health technologies
5.2.4 CHALLENGES
5.2.4.1 Concerns regarding inaccurate and inconsistent data
5.2.4.2 Reluctance to adopt healthcare analytics solutions in developing countries
5.2.4.3 Lack of maintenance of medical records
5.2.4.4 Shortage of skilled personnel
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 INDUSTRY TRENDS
5.4.1 INCREASING PARTNERSHIPS AND COLLABORATIONS AMONG MARKET PLAYERS
5.4.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS
5.4.3 GROWING ADOPTION OF CLOUD-BASED IT SOLUTIONS
5.5 ECOSYSTEM ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 TECHNOLOGY ANALYSIS
5.7.1 KEY TECHNOLOGIES
5.7.1.1 Big data analytics
5.7.1.2 Artificial intelligence and machine learning
5.7.1.3 Business intelligence tools
5.7.2 ADJACENT TECHNOLOGIES
5.7.2.1 Cloud computing
5.7.2.2 Internet of things
5.8 REGULATORY LANDSCAPE
5.8.1 REGULATORY ANALYSIS
5.8.2 GOVERNMENT REGULATIONS
5.8.2.1 US
5.8.2.2 Europe
5.8.2.3 China
5.8.2.4 Japan
5.8.2.5 India
5.8.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT
5.9.2 AVERAGE SELLING PRICE, BY REGION
5.10 PORTER’S FIVE FORCES ANALYSIS
5.11 PATENT ANALYSIS
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.12.2 BUYING CRITERIA
5.13 END-USER ANALYSIS
5.13.1 UNMET NEEDS
5.13.2 END-USER EXPECTATIONS
5.14 KEY CONFERENCES AND EVENTS, 2024–2025
5.15 CASE STUDY ANALYSIS
5.16 BUSINESS MODEL ANALYSIS
5.17 INVESTMENT AND FUNDING SCENARIO
5.18 IMPACT OF AI/GEN AI ON HEALTHCARE ANALYTICS MARKET
5.18.1 KEY USE CASES
5.18.2 CASE STUDY ON AI/GEN AI
5.18.3 ADJACENT MARKET ECOSYSTEM
5.18.3.1 Life science analytics market
5.18.3.2 Healthcare IT market
5.18.3.3 Healthcare fraud analytics market
5.18.4 USER READINESS AND IMPACT ASSESSMENT
5.18.4.1 User readiness
5.18.4.1.1 Payers
5.18.4.1.2 Providers
5.18.4.2 Impact assessment
5.18.4.2.1 User A: Payers
5.18.4.2.1.1 Implementation
5.18.4.2.1.2 Impact
5.18.4.2.2 User B: Providers
5.18.4.2.2.1 Implementation
5.18.4.2.2.2 Impact
6 HEALTHCARE ANALYTICS MARKET, BY COMPONENT
6.1 INTRODUCTION
6.2 SERVICES
6.2.1 MANAGED SERVICES
6.2.1.1 Analytical services
6.2.1.1.1 Increasing volume of healthcare data to facilitate growth
6.2.1.2 Consulting services
6.2.1.2.1 Need to improve clinical outcomes and patient satisfaction to support growth
6.2.2 PROFESSIONAL SERVICES
6.2.2.1 Training & implementation services
6.2.2.1.1 Growing emphasis on value-based care and specialized training services to drive market
6.2.2.2 Maintenance & support services
6.2.2.2.1 Expanding research needs to propel demand for maintenance & support services
6.3 SOFTWARE
6.3.1 ON-PREMISE SOFTWARE
6.3.1.1 Provision of multi-vendor architecture and security benefits to drive market
6.3.2 CLOUD-BASED SOFTWARE
6.3.2.1 Real-time analysis and elimination of purchasing costs for software & hardware to drive adoption
7 HEALTHCARE ANALYTICS MARKET, BY TYPE
7.1 INTRODUCTION
7.2 DESCRIPTIVE ANALYTICS
7.2.1 INCREASING USE IN PATIENT POPULATION MANAGEMENT AND FINANCIAL MANAGEMENT TO BOOST MARKET
7.3 PREDICTIVE ANALYTICS
7.3.1 ABILITY OF PREDICTIVE ANALYTICS TO HELP HEALTHCARE ORGANIZATIONS AVOID PREVENTABLE EVENTS TO SUPPORT GROWTH
7.4 PRESCRIPTIVE ANALYTICS
7.4.1 NEED FOR BETTER TREATMENT METHODS AND BUSINESS PRACTICES TO ENCOURAGE GROWTH
7.5 DIAGNOSTIC ANALYTICS
7.5.1 RISE IN LAUNCHES OF AI-DRIVEN ANALYTICS PRODUCTS AND SERVICES TO EXPEDITE GROWTH
8 HEALTHCARE ANALYTICS MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 FINANCIAL ANALYTICS
8.2.1 CLAIMS PROCESSING
8.2.1.1 Increasing shift from paper-based claims processing to electronic mode to augment growth
8.2.2 REVENUE CYCLE MANAGEMENT
8.2.2.1 Growing focus on financial forecasting and budgeting process to boost market
8.2.3 PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE
8.2.3.1 Implementation of ICD-10 code sets and adoption of fee-for-value systems to drive market
8.2.4 RISK ADJUSTMENT & ASSESSMENT
8.2.4.1 Rise in special enrollment periods and new subsidies to accelerate growth
8.3 CLINICAL ANALYTICS
8.3.1 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
8.3.1.1 Growing adoption of benchmarking to identify negative issues impacting healthcare systems to drive market
8.3.2 CLINICAL DECISION SUPPORT
8.3.2.1 Need to reduce medical errors and expedite diagnosis to boost market
8.3.3 REPORTING & COMPLIANCE
8.3.3.1 Ability to track regulatory changes, assess non-compliance, and perform internal audits to sustain growth
8.3.4 COMPARATIVE ANALYTICS/EFFECTIVENESS
8.3.4.1 Growing adoption of electronic health records to fuel market
8.3.5 PRECISION HEALTH/REAL-WORLD EVIDENCE
8.3.5.1 Strong government support for personalized medicine to sustain growth
8.3.6 MEDICAL IMAGING ANALYTICS
8.3.6.1 Ability to provide real-time insights and diagnosis of genetic disorders to aid growth
8.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS
8.4.1 SUPPLY CHAIN ANALYTICS
8.4.1.1 Growing need to reduce healthcare costs and implement better inventory management practices to fuel market
8.4.2 WORKFORCE ANALYTICS
8.4.2.1 Need for effective recruitment to favor growth
8.4.3 STRATEGIC ANALYTICS
8.4.3.1 Growing use of advanced analytics tools for geographic expansion and service line expansion to drive market
8.5 POPULATION HEALTH ANALYTICS
8.5.1 RISING USE IN CLINICAL OUTCOME ENGAGEMENT AND POPULATION RISK MANAGEMENT TO SPUR GROWTH
9 HEALTHCARE ANALYTICS MARKET, BY END USER
9.1 INTRODUCTION
9.2 PAYERS
9.2.1 PRIVATE INSURANCE COMPANIES
9.2.1.1 Increasing reliance on analytics for fraud prevention and claims processing to contribute to growth
9.2.2 GOVERNMENT AGENCIES
9.2.2.1 Rising use of analytics solutions to maximize payment accuracy and set reimbursement rates to boost market
9.3 PROVIDERS
9.3.1 HOSPITALS & CLINICS
9.3.1.1 Growing adoption of healthcare analytics solutions by large hospitals, medical groups, and physician practices to boost market
9.3.2 POST-ACUTE CARE ORGANIZATIONS
9.3.2.1 Increasing use of analytics solutions to review and study patient data to drive market
9.3.3 AMBULATORY SURGERY CENTERS
9.3.3.1 Need to control healthcare costs to support market
9.3.4 OTHER PROVIDERS
9.4 PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN
9.4.1 MANUFACTURERS
9.4.1.1 Growing adoption of digital technologies to drive market
9.4.2 DISTRIBUTORS & WHOLESALERS
9.4.2.1 Need for improved supply chain operations, inventory management, and service delivery to boost market
9.4.3 RETAILERS
9.4.3.1 Rising integration of healthcare analytics into retail operations to stimulate growth
10 HEALTHCARE ANALYTICS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 High adoption of electronic health records to drive market
10.2.3 CANADA
10.2.3.1 Need for managing patient volumes, clinical data, and healthcare costs to favor market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Government initiatives to increase use of analytics in healthcare
10.3.3 UK
10.3.3.1 Availability of venture capital investments to drive market
10.3.4 FRANCE
10.3.4.1 Strong financial support for digital health to augment market
10.3.5 ITALY
10.3.5.1 Growing number of drug approvals to drive uptake of analytics solutions
10.3.6 SPAIN
10.3.6.1 Growing adoption of personalized medicine to drive market
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Rising geriatric population to drive demand for effective patient management solutions
10.4.3 CHINA
10.4.3.1 Favorable reforms and growing number of electronic health records to aid growth
10.4.4 INDIA
10.4.4.1 Favorable government initiatives to fuel market
10.4.5 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Growing adoption of digital solutions in healthcare to boost market
10.5.3 MEXICO
10.5.3.1 Growing prominence of startups and rising R&D activity to propel market
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Rising investments, advancements, and developing healthcare infrastructure to drive market
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2024
11.3 REVENUE ANALYSIS, 2019–2023
11.4 MARKET SHARE ANALYSIS, 2023
11.5 COMPANY EVALUATION AND FINANCIAL METRICS
11.6 BRAND/SOFTWARE COMPARISON
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.7.1 STARS
11.7.2 EMERGING LEADERS
11.7.3 PERVASIVE PLAYERS
11.7.4 PARTICIPANTS
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.7.5.1 Company footprint
11.7.5.2 Region footprint
11.7.5.3 Component footprint
11.7.5.4 Application footprint
11.7.5.5 End-user footprint
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.8.1 PROGRESSIVE COMPANIES
11.8.2 RESPONSIVE COMPANIES
11.8.3 DYNAMIC COMPANIES
11.8.4 STARTING BLOCKS
11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.8.5.1 Detailed list of key startups/SMEs
11.8.5.2 Competitive benchmarking of key startups/SMEs
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES
11.9.2 DEALS
11.9.3 EXPANSIONS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 MERATIVE
12.1.1.1 Business overview
12.1.1.2 Products/Solutions/Services offered
12.1.1.3 Recent developments
12.1.1.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.1.3.2 Deals
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 SAS INSTITUTE INC.
12.1.2.1 Business overview
12.1.2.2 Products/Solutions/Services offered
12.1.2.3 Recent developments
12.1.2.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 OPTUM, INC.
12.1.3.1 Business overview
12.1.3.2 Products/Solutions/Services offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 ORACLE
12.1.4.1 Business overview
12.1.4.2 Products/Solutions/Services offered
12.1.4.3 Recent developments
12.1.4.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.4.3.2 Deals
12.1.4.3.3 Expansions
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses and competitive threats
12.1.5 VERADIGM LLC
12.1.5.1 Business overview
12.1.5.2 Products/Solutions/Services offered
12.1.5.3 Recent developments
12.1.5.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.5.3.2 Deals
12.1.5.3.3 Expansions
12.1.5.3.4 Other developments
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses and competitive threats
12.1.6 EXLSERVICE HOLDINGS, INC.
12.1.6.1 Business overview
12.1.6.2 Products/Solutions/Services offered
12.1.6.3 Recent developments
12.1.6.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.6.3.2 Deals
12.1.6.3.3 Other developments
12.1.7 CITIUSTECH INC.
12.1.7.1 Business overview
12.1.7.2 Products/Solutions/Services offered
12.1.7.3 Recent developments
12.1.7.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.7.3.2 Deals
12.1.7.3.3 Expansions
12.1.7.3.4 Other developments
12.1.8 HEALTH CATALYST
12.1.8.1 Business overview
12.1.8.2 Products/Solutions/Services offered
12.1.8.3 Recent developments
12.1.8.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.8.3.2 Deals
12.1.9 CVS HEALTH
12.1.9.1 Business overview
12.1.9.2 Products/Solutions/Services offered
12.1.9.3 Recent developments
12.1.9.3.1 Deals
12.1.10 INOVALON
12.1.10.1 Business overview
12.1.10.2 Products/Solutions/Services offered
12.1.10.3 Recent developments
12.1.10.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.10.3.2 Deals
12.1.10.3.3 Expansions
12.1.10.3.4 Other developments
12.1.11 MCKESSON CORPORATION
12.1.11.1 Business overview
12.1.11.2 Products/Solutions/Services offered
12.1.11.3 Recent developments
12.1.11.3.1 Deals
12.1.12 MEDEANALYTICS, INC.
12.1.12.1 Business overview
12.1.12.2 Products/Solutions/Services offered
12.1.12.3 Recent developments
12.1.12.3.1 Deals
12.1.12.3.2 Other developments
12.1.13 COTIVITI, INC.
12.1.13.1 Business overview
12.1.13.2 Products/Solutions/Services offered
12.1.13.3 Recent developments
12.1.13.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.13.3.2 Other developments
12.1.14 APIXIO, INC.
12.1.14.1 Business overview
12.1.14.2 Products/Solutions/Services offered
12.1.14.3 Recent developments
12.1.14.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.14.3.2 Deals
12.1.15 ENLITIC
12.1.15.1 Business overview
12.1.15.2 Products/Solutions/Services offered
12.1.15.3 Recent developments
12.1.15.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.15.3.2 Deals
12.1.16 KOMODO HEALTH, INC.
12.1.16.1 Business overview
12.1.16.2 Products/Solutions/Services offered
12.1.16.3 Recent developments
12.1.16.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
12.1.16.3.2 Deals
12.1.17 HEALTHEC, LLC
12.1.17.1 Business overview
12.1.17.2 Products/Solutions/Services offered
12.1.17.3 Recent developments
12.1.17.3.1 Deals
12.1.18 IQVIA
12.1.18.1 Business overview
12.1.18.2 Products/Solutions/Services offered
12.1.18.3 Recent developments
12.1.18.3.1 Deals
12.1.19 WIPRO
12.1.19.1 Business overview
12.1.19.2 Products/Solutions/Services offered
12.2 OTHER PLAYERS
12.2.1 ARCADIA SOLUTIONS, LLC.
12.2.2 EVIDATION HEALTH, INC.
12.2.3 HEALTHCORUM
12.2.4 AETION, INC.
12.2.5 TREDENCE.INC.
12.2.6 SISENSE LTD.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
